Connor, Clark & Lunn Investment Management »

Karyopharm Therapeutics shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $62k 71k 0.87
2023-09-30 $47k 35k 1.34
2023-06-30 $67k 38k 1.79
2023-03-31 $729k 188k 3.89
2022-12-31 $1.5M 432k 3.40
2022-09-30 $849k 155k 5.46
2022-06-30 $207k 46k 4.50
2019-06-30 $346k 58k 6.00
2019-03-31 $765k 131k 5.84
2016-03-31 $244k 27k 8.94
2015-12-31 $545k 41k 13.26
2015-09-30 $422k 40k 10.53
2015-06-30 $1.2M 46k 27.20
2015-03-31 $1.3M 44k 30.61
2014-12-31 $412k 11k 37.45